Oligodendrocytes in Adrenoleukodystrophy

Oligodendrocytes in Adrenoleukodystrophy

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Oligodendrocytes in Adrenoleukodystrophy</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Glial Cells</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Cerebral white matter</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Oligodendrocytes</td>
</tr>
<tr>
<td class="label">Key Gene</td>
<td>ABCD1 (X-linked ALD)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Stage</td>
<td>Pathological Event</td>
</tr>
<tr>
<td class="label">Stage 1</td>
<td>VLCFA accumulation in oligodendrocytes</td>
</tr>
<tr>
<td class="label">Stage 2</td>
<td>Myelin instability and dysfunction</td>
</tr>
<tr>
<td class="label">Stage 3</td>
<td>Oligodendrocyte death and demyelination</td>
</tr>
<tr>
<td class="label">Stage 4</td>
<td>Axonal degeneration</td>
</tr>
<tr>
<td class="label">Stage 5</td>

Oligodendrocytes in Adrenoleukodystrophy

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Oligodendrocytes in Adrenoleukodystrophy</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Glial Cells</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Cerebral white matter</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Oligodendrocytes</td>
</tr>
<tr>
<td class="label">Key Gene</td>
<td>ABCD1 (X-linked ALD)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Stage</td>
<td>Pathological Event</td>
</tr>
<tr>
<td class="label">Stage 1</td>
<td>VLCFA accumulation in oligodendrocytes</td>
</tr>
<tr>
<td class="label">Stage 2</td>
<td>Myelin instability and dysfunction</td>
</tr>
<tr>
<td class="label">Stage 3</td>
<td>Oligodendrocyte death and demyelination</td>
</tr>
<tr>
<td class="label">Stage 4</td>
<td>Axonal degeneration</td>
</tr>
<tr>
<td class="label">Stage 5</td>
<td>Inflammatory response and gliosis</td>
</tr>
<tr>
<td class="label">Form</td>
<td>Age of Onset</td>
</tr>
<tr>
<td class="label">Childhood cerebral ALD</td>
<td>4-10 years</td>
</tr>
<tr>
<td class="label">Adrenomyelononeuropathy (AMN)</td>
<td>Adulthood</td>
</tr>
<tr>
<td class="label">Addison-only</td>
<td>Variable</td>
</tr>
</table>

Adrenoleukodystrophy (ALD) is a peroxisomal metabolic disorder characterized by the accumulation of very long-chain fatty acids (VLCFAs) in tissues throughout the body, particularly in the white matter of the brain and the adrenal cortex. X-linked adrenoleukodystrophy (X-ALD), caused by mutations in the ABCD1 gene, is the most common form and leads to progressive demyelination of the central nervous system[@kemp2012].

Oligodendrocytes, the myelin-producing cells of the central nervous system, are particularly vulnerable in ALD due to their high lipid content and dependence on peroxisomal function. VLCFA accumulation in oligodendrocytes disrupts normal myelin synthesis and maintenance, leading to progressive white matter pathology[@barker2015].

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: immature neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:4042028)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)
• [OBO Foundry (CL:4042028)](http://purl.obolibrary.org/obo/CL_4042028)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:4042028)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)
• [OBO Foundry (CL:4042028)](http://purl.obolibrary.org/obo/CL_4042028)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Oligodendrocyte Function

• Myelin Production: Axonal insulation
• Saltatory Conduction: Rapid nerve transmission
• Metabolic Support: Lactate delivery to axons
• Ion Homeostasis: Potassium regulation

Role in Adrenoleukodystrophy

Peroxisomal Dysfunction and VLCFA Metabolism

The ABCD1 gene encodes the peroxisomal ABC transporter ALD protein (ALDP), which is responsible for importing VLCFAs into peroxisomes for β-oxidation. Mutations in ABCD1 lead to impaired VLCFA catabolism and subsequent accumulation[@moser2012].

Metabolic consequences in oligodendrocytes:

• VLCFA accumulation in myelin membranes disrupts lipid raft organization
• Abnormal VLCFA incorporation into myelin basic protein (MBP) affects myelin stability
• Endoplasmic reticulum stress due to lipid dysregulation
• Mitochondrial dysfunction secondary to membrane abnormalities

Pathological Cascade

Inflammatory Demyelination

• Activated microglia phagocytose damaged myelin
• Pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) released
• Blood-brain barrier disruption allows peripheral immune cell infiltration
• Inflammation accelerates demyelination in a feed-forward loop

Clinical Forms of X-ALD

Treatment Options

Dietary therapy:

• Lorenzo's oil: 4:1 ratio of oleic to erucic acid, reduces VLCFA levels[@heyers2020]
• Must be initiated before symptom onset for maximum benefit
• Does not reverse established damage

• Hematopoietic stem cell transplantation: Replaces microglia with functional cells[@eichler2006]
• Gene therapy (Skysona): Autologous hematopoietic stem cell transduction with functional ABCD1 gene[@cartridge2022]
• Most effective when administered early in disease course

Future Therapeutic Approaches

• Gene editing technologies (CRISPR-Cas9)
• Peroxisome-targeted small molecules
• Anti-inflammatory interventions
• Remyelination-promoting therapies

Background

The study of Oligodendrocytes In Adrenoleukodystrophy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Myelin](/cell-types/myelinating-oligodendrocytes)
• [White Matter](/conditions/white-matter-disorders)
• [Peroxisomal Disorders](/diseases/peroxisomal-disorders)
• [Demyelination](/mechanisms/demyelination)
• [Adrenoleukodystrophy](/diseases/adrenoleukodystrophy)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Pathway Diagram

The following diagram shows the key molecular relationships involving Oligodendrocytes in Adrenoleukodystrophy discovered through SciDEX knowledge graph analysis: